Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 2,311,925 | 2,326,310 | 2,093,948 | 2,074,024 | 1,956,084 |
| Accounts payable and accrued liabilities | -1,818,575 | -1,989,685 | -1,916,119 | -1,808,687 | -1,730,062 |
| Other Working Capital | 425,939 | 251,508 | 103,469 | 218,736 | 173,514 |
| Other Operating Activity | -461,392 | -302,639 | -177,161 | -268,007 | -213,326 |
| Operating Cash Flow | $457,897 | $285,494 | $104,137 | $216,066 | $186,210 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -39,918 | -68,695 | 16,114 | -58,542 | -49,220 |
| PPE Investments | -98,403 | -125,510 | -111,246 | -141,038 | -111,921 |
| Net Acquisitions | -79,386 | 7,230 | -76,645 | -14,165 | -4,356 |
| Purchase Sale Intangibles | 8,818 | -3 | -3,795 | -135 | -1,372 |
| Other Investing Activity | 8,818 | -3 | -3,795 | -135 | -1,372 |
| Investing Cash Flow | $-208,889 | $-186,978 | $-175,572 | $-213,880 | $-166,869 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | -316 | -303 | -282 |
| Debt Repayment | -643 | -2,961 | N/A | N/A | N/A |
| Common Stock Issued | 16,944 | 14,133 | 14,604 | 11,280 | 8,236 |
| Common Stock Repurchased | -28,000 | -48,912 | -2,920 | N/A | N/A |
| Other Financing Activity | -11,059 | -10,940 | -11,027 | -1,957 | 627 |
| Financing Cash Flow | $-22,758 | $-48,680 | $341 | $9,020 | $8,581 |
| Exchange Rate Effect | 2,237 | -655 | -1,094 | -12,858 | 16,376 |
| Beginning Cash Position | 434,164 | 384,983 | 457,171 | 458,823 | 413,251 |
| End Cash Position | 662,651 | 434,164 | 384,983 | 457,171 | 457,549 |
| Net Cash Flow | $228,487 | $49,181 | $-72,188 | $-1,652 | $44,298 |
| Free Cash Flow | |||||
| Operating Cash Flow | 457,897 | 285,494 | 104,137 | 216,066 | 186,210 |
| Capital Expenditure | -98,532 | -129,825 | -111,332 | -141,436 | -112,000 |
| Free Cash Flow | 359,365 | 155,669 | -7,195 | 74,630 | 74,210 |